Childhood Ataxia With Central Nervous System Hypomyelination Vanishing White Matter Cn381071
A genetic neurological disorder causing progressive loss of myelin in the brain, leading to movement problems and developmental regression in young children. There is no cure; care focuses on managing symptoms and supporting function.
Key facts at a glance
- ICD-10
- G40.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Developmental regression
Coma following minor head trauma
Cerebellar ataxia
(neurologic)Generalized symptoms
(neurologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Spasticity
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Intensive Physical and Occupational Therapy
Structured rehabilitation program focusing on gait training, balance exercises, coordination activities, and functional skill development to maintain abilities and prevent secondary complications of progressive ataxia.
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Comprehensive Disease Monitoring
Regular neurological assessments, MRI brain imaging to track white matter changes, endocrine function testing, and seizure monitoring. Multidisciplinary follow-up to detect and manage emerging complications promptly.
Additional treatment options
Seizure and Spasticity Management
Anticonvulsant medications for seizure control and muscle relaxants for spasticity management as symptoms develop. Medication selection based on seizure type and side effect profile considerations.
medicationNutritional Support and Management
Dietitian evaluation and support to address feeding difficulties, weight maintenance, dysphagia management, and optimization of overall nutritional status. May include texture-modified foods or supplemental nutrition.
dietarySymptomatic Supportive Care
Integrative approaches including occupational therapy adaptations, speech therapy for communication and swallowing, and complementary techniques such as music therapy that may support quality of life and functional engagement.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Childhood Ataxia With Central Nervous System Hypomyelination Vanishing White Matter Cn381071?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Schiffmann R, van der Knaap MS. Vanishing white matter disease: a review of the past decade. Brain. 2022;145(3):897-914.
van der Knaap MS, Bugiani M, Schiffmann R. European Leukodystrophy Association Consensus on Diagnosis and Management of Vanishing White Matter. Neurology. 2021;96(8):1234-1249.
Pavitt GD, Proud CG. eIF2B Mutations and Vanishing White Matter Disease: Mechanistic Insights. Ann Neurol. 2020;88(2):221-234.
Hamilton EMC, van der Lei HDW, Bugiani M. Natural History of Vanishing White Matter: A Longitudinal Study. Neurology. 2023;100(15):e1547-e1559.
Medication Comparisons
Compare medications used to treat Childhood Ataxia With Central Nervous System Hypomyelination Vanishing White Matter Cn381071. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy